J. Y. Han et al. indicated that SCH66336 inhibits angiogenic activities of NSCLC cells by decreasing hypoxia and also reduction in VEGF production probably by the interaction between HIF-1α and Hsp90, resulting in the proteasomal degradation of HIF-1α [47]. The gene discussed is VEGFA; the disease is non-small cell lung carcinoma.